Should You Buy Arrowhead Pharmaceuticals Inc (ARWR) in Biotechnology Industry?

Arrowhead Pharmaceuticals Inc (ARWR) is around the top of the Biotechnology industry according to InvestorsObserver. ARWR received an overall rating of 63, which means that it scores higher than 63 percent of all stocks. Arrowhead Pharmaceuticals Inc also achieved a score of 71 in the Biotechnology industry, putting it above 71 percent of Biotechnology stocks. Biotechnology is ranked 34 out of the 148 industries.

ARWR has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on ARWR!

See Full ARWR Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Arrowhead Pharmaceuticals Inc Stock Today?

Arrowhead Pharmaceuticals Inc (ARWR) stock is trading at $42.95 as of 3:34 PM on Wednesday, Aug 24, a gain of $1.73, or 4.2% from the previous closing price of $41.22. The stock has traded between $40.98 and $43.12 so far today. Volume today is 704,938 compared to average volume of 715,475. Click Here to get the full Stock Report for Arrowhead Pharmaceuticals Inc stock.